Gene therapy using genome‐edited <scp>iPS</scp> cells for targeting malignant glioma
Ryota Tamura(Keio University Hospital), Masahiro Toda(Keio University Hospital)
Cited by 14
Related Papers
Current Understanding of Neurofibromatosis Type 1, 2, and Schwannomatosis
|International Journal of Molecular Sciences|2021|231
The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications
|Medical Oncology|2019|219
Analysis of Tumor Angiogenesis and Immune Microenvironment in Non-Functional Pituitary Endocrine Tumors
|Journal of Clinical Medicine|2019|79
Histopathological investigation of glioblastomas resected under bevacizumab treatment
|Oncotarget|2016|55
Subarachnoid hemorrhage triggers neuroinflammation of the entire cerebral cortex, leading to neuronal cell death
|Inflammation and Regeneration|2022|33